Skip to content

Clinical trials

Phase 3 Carcinoma, Non-Small-Cell Lung trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 3 Country / region: Taiwan Clear all

165 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20042
20054
20066
20076
20087
20097
20103
20111
20124
20133
20145
201510
20165
20177
201810
20197
202011
20216
202212
202310
202415
202512
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68
Active, not recruiting43
Recruiting32
Terminated21
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca24
Merck Sharp & Dohme LLC20
Eli Lilly and Company15
Pfizer12
Bristol-Myers Squibb11
Hoffmann-La Roche11
Boehringer Ingelheim7
Novartis Pharmaceuticals7
Daiichi Sankyo4
Janssen Research & Development, LLC4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung165
Lung Neoplasms27
Carcinoma10
Neoplasm Metastasis9
Neoplasms6
Adenocarcinoma5
Carcinoma, Large Cell5
Carcinoma, Squamous Cell5
Lung Diseases3
Adenocarcinoma of Lung2

Trials

Showing 1 to 25 of 165. Each trial links to its page on Pharma Observatory.

65 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.